Viasys Buys BioBeat

Viasys of West Conshohocken, PA has bought BioBeat Medical Ltd., an ultrasound doppler systems’ manufacturer, for $4.5 million, according to the Philadelphia Business Journal.

The deal give Viasys’ NeuroCare division two new products – Sonara and Sonara/tek – that feature advanced digital transcranial doppler, or TCD, technology. TCD is a non-invasive method of measuring blood flow velocities in the arteries of the brain using ultrasound technology.

Viasys officials said Sonara and Sonara/tek will be launched this month to the European market. The products formerly of the Kadima, Israel-based company are under review by the FDA.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters